David C. Hooper

Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase

Ari Robicsek, Jacob Strahilevitz, George A. Jacoby et al. · Nature Medicine · 2005 · 1K citations

Life Sciences, Biochemistry, Pharmacology +14

<i>Enterobacter</i> Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy

Joseph W. Chow, Michael J. Fine, David M. Shlaes et al. · Annals of Internal Medicine · 1991 · 895 citations

Life Sciences, Infectious Diseases, Microbiology +17

Prevalence in the United States of <i>aac(6</i> ′ <i>)</i> - <i>Ib</i> - <i>cr</i> Encoding a Ciprofloxacin-Modifying Enzyme

Chi Hye Park, Ari Robicsek, George A. Jacoby et al. · Antimicrobial Agents and Chemotherapy · 2006 · 750 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

J S Wolfson, David C. Hooper · Antimicrobial Agents and Chemotherapy · 1985 · 700 citations

Medicine, Medicinal Chemistry, Pharmacology +6

<i>qnr</i> Prevalence in Ceftazidime-Resistant <i>Enterobacteriaceae</i> Isolates from the United States

Ari Robicsek, Jacob Strahilevitz, D.F. Sahm et al. · Antimicrobial Agents and Chemotherapy · 2006 · 575 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15